Business news today captures an economy still being reshaped by supply constraints, strategic investment and stubborn costs. In pharma, Dr. Reddy’s has delayed semaglutide supplies after finding an active ingredient quality issue, a setback that is expected to push it short of annual targets even as the company says patient safety is unaffected. In chips, Micron won investor approval with plans to invest up to $3 billion to deepen the U.S. semiconductor supply chain, underscoring how manufacturers are racing to secure capacity amid strong memory demand. India is making a similar infrastructure play, with Gujarat unveiling an ambitious data-centre policy aimed at attracting ₹6 lakh crore and 7.5 gigawatts of capacity. Meanwhile, the U.S. housing market remains painfully unaffordable as record home prices collide with higher mortgage rates and weaker sales. And in Europe, Hugo Boss is telling shareholders to reject Frasers’ takeover approach as too low.